Marc Dechamps

Chief Executive Officer at Bioxodes

📍 Waterloo, Walloon Region, Belgium🔄 Updated October 2026💼 4 investments📅 7 years investing🗓 Last invested Jun 2024
VC🌍 Belgium
4
Total investments
1
Early stage
0
Mid stage
2
Late stage
7y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Mar 2022
The HealthTech For Care endowment fund has three essential missions: - fostering the growth and development of the entire health ecosystem, - advocating for the advancement of innovative therapies and treatments to benefit patients, - promoting enhanced access to care for patients within the European healthcare ecosystem.
Board Member
Apr 2019
The Council of European BioRegions is a network of clusters and bio communities across Europe and worldwide, with the mission to defragment biotechnology and its support in Europe. CEBR represents more than 40 subscription members in Europe and a large number of clusters partners across the world. From emerging clusters to mature ones, with members including life science business network, science parks, regional development agencies and incubators. Together, we represent and support a critical mass of SMEs as well as Universities and Research Centres. Our Vision To strengthen transfer of knowledge and collaboration between life science clusters and ecosystems in Europe and support sustainable growth for SMEs, creating a competitive Europe in the global economy. Our Mission Create a European platform for cluster/network development & collaboration. Increase visibility of clusters/ bioregions and their contribution to sustainable growth. Joint activities to support SME development. For more information, please visit our website: www.cebr.net
Board Member
2019
The Council of European BioRegions is a network of clusters and bio communities across Europe and worldwide, with the mission to defragment biotechnology and its support in Europe. CEBR represents more than 40 subscription members in Europe and a large number of clusters partners across the world. From emerging clusters to mature ones, with members including life science business network, science parks, regional development agencies and incubators. Together, we represent and support a critical mass of SMEs as well as Universities and Research Centres. Our Vision To strengthen transfer of knowledge and collaboration between life science clusters and ecosystems in Europe and support sustainable growth for SMEs, creating a competitive Europe in the global economy. Our Mission Create a European platform for cluster/network development & collaboration. Increase visibility of clusters/ bioregions and their contribution to sustainable growth. Joint activities to support SME development. For more information, please visit our website: www.cebr.net
Experience · 9 entries
All (9)
Investments (4)
Founder (1)
Board (4)
2024
Independent Board Member
Jun 2024
OSE Immunotherapeutics, a biotech dedicated to developing first-in-class assets in immuno-oncology (IO) & immuno-inflammation (I&I). • Tedopi® (therapeutic cancer vaccine): Registration Phase 3 in 2nd-line NSCLC in HLA-A2+ patients with secondary resistance. Phase 2 trials, sponsored by onco groups, of Tedopi® in combo in solid tumors. • Lusvertikimab (mAb IL-7R antagonist); Positive Phase 2 in UC; preclinical research in ALL. • OSE-279 (anti-PD1): 1st positive results in Phase 1/2 in solid tumors. • FR-104/VEL-101 (anti-CD28 mAb): developed in partnership with Veloxis in transplant; Phase 1/2 in renal transplant (CHU Nantes); successful Phase 1 in the US (Veloxis). • Anti-SIRPα mAb developed in partnership with Boehringer Ingelheim in advanced solid tumors & cardiovascular-renal-metabolic diseases; positive Phase 1 dose escalation results in monotherapy and combo; Phase 2 in CRM diseases planned end 2024. • ABBV-230 (ChemR23 agonist mAb) developed in partnership with AbbVie in chronic inflammation. 4 proprietary drug discovery platforms • Pro-resolutive mAb platform • Myeloid Checkpoint platform • BiCKI® Platform • mRNA Therapeutic platform f
2022
Academic Director - Advanced Master in Biotech & MedTech Ventures
Mar 2022
Founded in 1903 by Ernest Solvay, renowned Belgian chemical industrial, the Solvay Brussels School of Economics and Management is a faculty of the Université Libre de Bruxelles, one of the largest universities in Belgium. Ever since, the school has built up a tradition of excellence and innovation in business and economics learning, fueled by deep connections within Belgium's multi-national entrepreneurial network. It currently holds a leading position in Europe for research and education in the fields of Economics and Management. Operating within the faculty, Solvay Lifelong Learning (SLL) is the best known and trusted executive education business school in Belgium on a mission to train business leaders and entrepreneurs with the ability to adapt to the ever-changing nature of society and to shape tomorrow’s world. We develop continuous education programmes addressing both young professionals as well as experienced managers and entrepreneurs committed to the logic of personal and sustainable development. SLL covers the main management practices like General Management to more specialised disciplines like Leadership, Digital Transformation, Finance, Innovation, Marketing, and much more. Our programme portfolio includes Open Enrolment Programmes (including short seminars, executive masters, MBA and Advanced Masters) and Customer-specific programmes (fully customised for companies).
Board Member
Mar 2022
The HealthTech For Care endowment fund has three essential missions: - fostering the growth and development of the entire health ecosystem, - advocating for the advancement of innovative therapies and treatments to benefit patients, - promoting enhanced access to care for patients within the European healthcare ecosystem.
2021
Chairman of the Board of Investsud Tech and Investsud Innovation
Oct 2021
ORSA (ex-Investsud) est un fonds d’investissement spécialisé dans le financement et l’accompagnement des PME wallonnes. Nous investissons entre 500 000 € et 2 500 000 € en capital et quasi-capital pour soutenir les projets d’innovation, de développement, de croissance et de transmission. Au-delà du financement, nous apportons un accompagnement stratégique de long terme. Depuis plus de 40 ans, nous mettons notre expertise financière et notre expérience du terrain au service des entrepreneurs, en nous impliquant à leurs côtés pour les aider à franchir les étapes décisives de leur développement. Doté de plus de 120 millions d’euros de moyens d’action, ORSA est un fond evergreen, ce qui lui permet d’intervenir avec un horizon de long terme, sans contrainte de sortie, afin de construire une valeur durable aux côtés des dirigeants. Nos investissements s’articulent autour de deux thématiques : – Industrie : production, équipement et construction – Innovation : santé, digital et durabilité Notre gouvernance associe capitaux privés et publics, portée majoritairement par des entrepreneurs wallons. Cette structure nous permet de conjuguer stabilité financière, vision entrepreneuriale et ancrage territorial. Oser ensemble. Nous sommes présents à chaque étape de la vie de votre entreprise pour : – Financer le développement de votre PME : Accélérez votre croissance sans compromettre votre indépendance. – Sécuriser et préparer l’avenir de votre PME : Préparez l’avenir de votre entreprise avec un associé durable. – Reprendre une PME : Concrétisez votre acquisition avec un accompagnement stratégique et financier. – Financer votre projet biotech : Développez votre innovation avec un associé qui comprend vos enjeux scientifiques. – Accélérer votre start-up / scale-up : Franchissez vos prochaines étapes de croissance avec un investisseur engagé.
2019
Board Member
Apr 2019
The Council of European BioRegions is a network of clusters and bio communities across Europe and worldwide, with the mission to defragment biotechnology and its support in Europe. CEBR represents more than 40 subscription members in Europe and a large number of clusters partners across the world. From emerging clusters to mature ones, with members including life science business network, science parks, regional development agencies and incubators. Together, we represent and support a critical mass of SMEs as well as Universities and Research Centres. Our Vision To strengthen transfer of knowledge and collaboration between life science clusters and ecosystems in Europe and support sustainable growth for SMEs, creating a competitive Europe in the global economy. Our Mission Create a European platform for cluster/network development & collaboration. Increase visibility of clusters/ bioregions and their contribution to sustainable growth. Joint activities to support SME development. For more information, please visit our website: www.cebr.net
Show all 9 entries ↓
Investment activity
2019–2024 · 4 investments
201922022120241
Recent (last 2 years)Earlier